Simon Urschel

Simon Urschel

Auto-generated profile, based on publicly available information

Simon Urschel

Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
SUSimon Urschel
Simon Urschel
ILIngrid M. Larsen
Ingrid M. Larsen
RKRichard Kirk
Richard Kirk
JFJulie Flett
Julie Flett
MBMichael Burch
Michael Burch
LWLori J. West
Lori J. West

1 October 2016 in Current Opinion in Pediatrics
Verified
Journal Article
Closed access
SUSimon Urschel
Simon Urschel
LWLori J. West
Lori J. West
Purpose of review: ABO-incompatible (ABOi) heart transplantation (HTx) in young children has evolved from an experimental approach to a standard allocation option in many countries. Clinical and immunological research in ABOi transplantation has revealed insight into the immature immune system and its role in superior graft acceptance in childhood and antigen-specific tolerance. Recent findings: Multicenter experience has confirmed equal actuarial survival, freedom from rejection, and graft vasculopathy comparing ABOi with ABO-compatible HTx. Observations of reduced antibody production and B-cell immunity toward the donor blood group have been confirmed in long-term follow-up. Mechanisms contributing to tolerance in this setting involve the interplay between B-cells and the complement system and the development of B-cell memory. Better characterization of the ABH polysaccharide antigens has improved diagnostic methods and clinical assessment of blood group antibodies. Boundaries regarding age, immune maturity, and therapeutic interventions to extend the applicability of ABOi HTx have been explored and resulted in data that may be useful for HTx patients beyond infancy and ABOi transplantation of other organs. Tolerance of ABH antigens possibly extends to HLA response. Summary: The review provides insight into the clinical evolution of ABOi HTx and associated immunologic discoveries. Current experiences and boundaries are discussed together with recent and potential future developments for utilization in other patient and age groups.

17 December 2009 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
SUS. Urschel
S. Urschel
PCP. M. Campbell
P. M. Campbell
SMS. R. Meyer
S. R. Meyer
ILI. M. Larsen
I. M. Larsen
JNJ. Nuebel
J. Nuebel
LWL. J. West
L. J. West
Specific B‐cell tolerance toward donor blood group antigens develops in infants after ABO‐incompatible heart transplantation, whereas their immune response toward protein antigens such as HLA has not been investigated. We assessed de novo HLA‐antibodies in 122 patients after pediatric thoracic transplantation (28 ABO‐incompatible) and 36 controls. Median age at transplantation was 1.7 years (1 day to 17.8 year) and samples were collected at median 3.48 years after transplantation. Antibodies were detected against HLA‐class I in 21 patients (17.2%), class II in 18 (14.8%) and against both classes in 10 (8.2%). Using single‐antigen beads, donor‐specific antibodies (DSAs) were identified in six patients (all class II, one additional class I). Patients with DSAs were significantly older at time of transplantation. In patients who had undergone pretransplant cardiac surgeries, class II antibodies were more frequent, although use of homografts or mechanical heart support had no influence. DSAs were absent in ABO‐incompatible recipients and class II antibodies were significantly less frequent than in children with ABO‐compatible transplants. This difference was present also when comparing only children transplanted below 2 years of age. Therefore, tolerance toward the donor blood group appears to be associated with an altered response to HLA beyond age‐related effects.

6 December 2018 in JCI Insight
Verified
Journal Article
Open access
PDF file
SISabine Ivison
Sabine Ivison
MMMehrnoush Malek
Mehrnoush Malek
RGRosa V. Garcia
Rosa V. Garcia
RBRaewyn Broady
Raewyn Broady
AHAnne Halpin
Anne Halpin
MLMegan K. Levings
Megan K. Levings
The analysis and validation of flow cytometry–based biomarkers in clinical studies are limited by the lack of standardized protocols that are reproducible across multiple centers and suitable for use with either unfractionated blood or cryopreserved PBMCs. Here we report the development of a platform that standardizes a set of flow cytometry panels across multiple centers, with high reproducibility in blood or PBMCs from either healthy subjects or patients 100 days after hematopoietic stem cell transplantation. Inter-center comparisons of replicate samples showed low variation, with interindividual variation exceeding inter-center variation for most populations (coefficients of variability 0.75). Exceptions included low-abundance populations defined by markers with indistinct expression boundaries (e.g., plasmablasts, monocyte subsets) or populations defined by markers sensitive to cryopreservation, such as CD62L and CD45RA. Automated gating pipelines were developed and validated on an independent data set, revealing high Spearman’s correlations ( r s >0.9) with manual analyses. This workflow, which includes pre-formatted antibody cocktails, standardized protocols for acquisition, and validated automated analysis pipelines, can be readily implemented in multicenter clinical trials. This approach facilitates the collection of robust immune phenotyping data and comparison of data from independent studies.

20 December 2022 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
AVAngela Velleca
Angela Velleca
MSMichael A Shullo
Michael A Shullo
KDKumud Dhital
Kumud Dhital
EAEstela Azeka
Estela Azeka
MCMonica Colvin
Monica Colvin
ZRZdenka Reinhardt
Zdenka Reinhardt

1 July 2020 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
SUSimon Urschel
Simon Urschel
MMMarie McCoy
Marie McCoy
RCRyan S. Cantor
Ryan S. Cantor
DKDevin A. Koehl
Devin A. Koehl
WZWarren A. Zuckerman
Warren A. Zuckerman
WCWaldemar F. Carlo
Waldemar F. Carlo